Using 3D models to help manage congenital diaphragmatic hernia in fetuses
Official title: The Role of 3D Images and Models to Aid Management of Cases of Congenital Diaphragmatic Hernia Diagnosed in the Antenatal Period. Consecutive Patients Studied From Diagnosis to Post Operative Period.
Run by Sheffield Teaching Hospitals NHS Foundation Trust · NCT03750266 · Data updated 2026-11-12
This study is trying to use 3D models made from MRI scans to help parents and doctors better understand and plan for surgery for fetuses with congenital diaphragmatic hernia.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | Sheffield Teaching Hospitals NHS Foundation Trust Academic / other |
| Locations | 1 site (Sheffield, South Yorkshire) |
| Status | Recruiting |
| Started | October 4, 2017 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | August 7, 2026 |
| Trial ID | NCT03750266 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women attending the Jessop Wing Fetal Medicine Unit whose fetuses have been diagnosed with CDH and are referred for MRI.
✕Probably not a fit
Patients who may not benefit include those unable to provide informed consent, under 18 years of age, or unable to undergo MRI due to claustrophobia or metal implants.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to create 3D animations and models of fetuses diagnosed with congenital diaphragmatic hernia (CDH) using routine medical imaging. By visualizing the size of the defect and the positioning of organs, the study seeks to enhance understanding for both parents and surgical teams. The approach leverages existing MRI scans to provide detailed insights without any additional interventions. This method could improve preoperative planning and parental education regarding the condition.
Why it matters
Potential benefit: If successful, this could lead to better surgical outcomes and improved understanding of CDH for families.
How similar studies have gone: While the use of 3D modeling in medical imaging is gaining traction, this specific application for CDH management is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Target Population: pregnancy women attending Jessop Wing Fetal medicine unit. * Accessible population: Pregnant women attending Jessop Wing Fetal medicine unit. Whose fetus had a CDH and are referred to MRI. * Study population: Pregnant women attending Jessop Wing Fetal medicine unit. Whose fetus had a CDH and are referred to MRI and agree to take part in the study. Exclusion Criteria: * Not able to give informed consent due to any reason including poor understanding of English * Under 18 years of age. * Unable to complete the fetal MRI process due to either metal implants or claustrophobia.
Where it's running
-
Jessop Wing Hospital
Sheffield, South Yorkshire, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Melatonin plus inhaled nitric oxide for pulmonary hypertension in full-term newborns
This study tests whether adding melatonin to inhaled nitric oxide helps treat pulmonary hypertension in full-term neonates.
-
FETO with a Goldballoon device for fetuses with diaphragmatic hernia
This study tests whether performing Fetoscopic Endoluminal Tracheal Occlusion on pregnancies with fetal diaphragmatic hernia improves baby survival and reduces long-term problems.
-
Fetal tracheal occlusion (FETO) for severe congenital diaphragmatic hernia
This trial will test whether fetal endoluminal tracheal occlusion (FETO) helps fetuses with severe congenital diaphragmatic hernia and intrathoracic liver herniation survive to hospital discharge.
-
Long-term outcomes after FETO for severe left or right congenital diaphragmatic hernia
This trial will test whether performing FETO in fetuses with isolated severe left or right CDH helps more babies survive to hospital discharge and have fewer long-term problems than standard care.
-
Fetal treatment for congenital diaphragmatic hernia
This study is testing a new way to treat congenital diaphragmatic hernia in unborn babies by placing a balloon in their airway to help their lungs grow before they are born.
-
Fetoscopic balloon (FETO) for severe left and right congenital diaphragmatic hernia — long-term outcomes
This trial will try placing and later removing a tiny balloon in the fetal windpipe around 27–29 weeks to help babies with severe congenital diaphragmatic hernia and liver herniation survive the newborn period.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.